This dichotomy might explain the lack of association with clinical outcomes in our cohort, particularly in a heterogeneous tumor like OSCC, where co-factors such as neurotrophin availability, receptor isoforms, and tumor microenvironmental context play a critical role. This evidence concerns the gene BDNF and neoplasm.